rs1047427572

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_012282.4(KCNE5):​c.410A>G​(p.Gln137Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000198 in 1,010,334 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 25)
Exomes 𝑓: 0.0000020 ( 0 hom. 0 hem. )

Consequence

KCNE5
NM_012282.4 missense

Scores

1
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0650

Publications

0 publications found
Variant links:
Genes affected
KCNE5 (HGNC:6241): (potassium voltage-gated channel subfamily E regulatory subunit 5) This gene encodes a member of a family of single pass transmembrane domain proteins that function as ancillary subunits to voltage-gated potassium channels. Members of this family affect diverse processes in potassium channel regulation, including ion selectivity, voltage dependence, and anterograde recycling from the plasma membrane. Variants of this gene are associated with idiopathic ventricular fibrillation and Brugada syndrome. [provided by RefSeq, Nov 2016]
ACSL4 (HGNC:3571): (acyl-CoA synthetase long chain family member 4) The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme preferentially utilizes arachidonate as substrate. The absence of this enzyme may contribute to the cognitive disability or Alport syndrome. Alternative splicing of this gene generates multiple transcript variants. [provided by RefSeq, Jan 2016]
ACSL4 Gene-Disease associations (from GenCC):
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Illumina, ClinGen, Orphanet
  • intellectual disability, X-linked 63
    Inheritance: XL Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.05408418).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012282.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNE5
NM_012282.4
MANE Select
c.410A>Gp.Gln137Arg
missense
Exon 1 of 1NP_036414.1Q9UJ90

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNE5
ENST00000372101.3
TSL:6 MANE Select
c.410A>Gp.Gln137Arg
missense
Exon 1 of 1ENSP00000361173.2Q9UJ90
ACSL4
ENST00000439581.1
TSL:3
n.387-290A>G
intron
N/A

Frequencies

GnomAD3 genomes
Cov.:
25
GnomAD4 exome
AF:
0.00000198
AC:
2
AN:
1010334
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
323732
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22479
American (AMR)
AF:
0.0000536
AC:
1
AN:
18658
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15564
East Asian (EAS)
AF:
0.0000378
AC:
1
AN:
26425
South Asian (SAS)
AF:
0.00
AC:
0
AN:
43048
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34760
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3371
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
803604
Other (OTH)
AF:
0.00
AC:
0
AN:
42425
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
25
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
12
DANN
Benign
0.95
DEOGEN2
Benign
0.063
T
FATHMM_MKL
Benign
0.010
N
LIST_S2
Benign
0.26
T
M_CAP
Benign
0.082
D
MetaRNN
Benign
0.054
T
MetaSVM
Benign
-1.0
T
PhyloP100
0.065
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-0.78
N
REVEL
Benign
0.054
Sift
Benign
0.13
T
Sift4G
Benign
0.86
T
Polyphen
0.0
B
Vest4
0.033
MutPred
0.22
Gain of MoRF binding (P = 3e-04)
MVP
0.13
MPC
0.41
ClinPred
0.043
T
GERP RS
-2.7
Varity_R
0.088
gMVP
0.053
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1047427572; hg19: chrX-108867840; API